Health Robotics Re-Acquires CytoCare Rights
Health Robotics and B. Braun Melsungen AG today announced that in exchange for undisclosed consideration, Health Robotics has re-acquired from B. Braun the exclusive marketing, sales, installation, implementation, interface, manufacturing, and technical support European rights for CytoCare, a robot designed to manufacture chemotherapy and hazardous IV Admixtures, and which rights B.Braun had previously acquired from Health Robotics in 2007 and 2008.
This amendment to the prior agreements includes the transition of all CytoCare customer contracts from B. Braun to direct Health Robotics' technical support, starting on July 1st, 2010.
“Health Robotics' current global dominance of the IV Robotics industry is in great part due to the support we received from B. Braun since 2006. We learned a lot through the last 42 months, especially in the area of flexibility supporting many different IV consumables, which has improved our robots not only for B. Braun's IV Bottles but also for Asia Pacific-based IV consumables,” stated Werner Rainer, Health Robotics' CEO.
Health Robotics is a leading supplier of intravenous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions.